Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial

Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial

Abstract Objectives Comparison of the effect of hydroxychloroquine with placebo to prevent infection from the COVID -19 virus among healthcare professionals Trial design Single centre, 2-arm, double-blind randomised (ratio 1:1) placebo-controlled trial Participants Treatment staff who are in contact...

Full description

Bibliographic Details
Main Authors:	Reihaneh Pirjani, Tahereh Soori, Ahmad Reza Dehpour, Mahdi Sepidarkish, Ashraf Moini, Arshia Shizarpour, Razieh Mohammad Jafari
Format:	Article
Language:	English
Published:	BMC 2020-06-01
Series:	Trials
Subjects:	COVID-19 Randomised controlled trial protocol hydroxychloroquine healthcare professionals prevention
Online Access:	http://link.springer.com/article/10.1186/s13063-020-04439-3

Similar Items

Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial
by: José Meneses Calderón, et al.
Published: (2020-06-01)

ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial
by: Carmel M. McEniery, et al.
Published: (2020-07-01)

A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial
by: Mohammad Bosaeed, et al.
Published: (2020-10-01)

Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial
by: Bharath Kumar Tirupakuzhi Vijayaraghavan, et al.
Published: (2020-08-01)

Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial
by: Antonio Cuadrado-Lavín, et al.
Published: (2020-06-01)

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
by: Pradeesh Sivapalan, et al.
Published: (2020-06-01)

Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial
by: Raquel González, et al.
Published: (2020-07-01)

Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial
by: Felicitas Stoll, et al.
Published: (2020-06-01)

Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial
by: Petri J. Vainio, et al.
Published: (2021-01-01)

Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial
by: Berta Grau-Pujol, et al.
Published: (2020-07-01)

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial
by: Justin T. Denholm, et al.
Published: (2020-07-01)

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial
by: Abolghasem Allahyari, et al.
Published: (2020-06-01)

Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial
by: Siri Göpel, et al.
Published: (2020-07-01)

Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada
by: Julie K. Wright, et al.
Published: (2020-07-01)

Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial
by: Ruanne V. Barnabas, et al.
Published: (2020-06-01)

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial
by: Javed Akram, et al.
Published: (2020-08-01)

Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial
by: Prasan Kumar Panda, et al.
Published: (2020-10-01)

PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial
by: Oriana Nanni, et al.
Published: (2020-07-01)

A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial
by: Sohaib Ashraf, et al.
Published: (2021-02-01)

The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2021-12-01)

Chloroquine and hydroxychloroquine for COVID-19 treatment
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2020-05-01)

The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition
by: Fahimeh Sheikhbahaie, et al.
Published: (2016-01-01)

Unusual Fundus Autofluorescence Appearance in a Patient with Hydroxychloroquine Retinal Toxicity
by: Sleiman Abou-Ltaif
Published: (2015-06-01)

The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
by: Arash Rahimi, et al.
Published: (2021-04-01)

Hydroxychloroquine retinopathy: A review of imaging
by: Hemang K Pandya, et al.
Published: (2015-01-01)

Hydroxychloroquine-induced auditory toxicity
by: Abhishek Patil, et al.
Published: (2020-01-01)

Therapeutic status of hydroxychloroquine in COVID-19: A review
by: Kirandeep Kaur, et al.
Published: (2020-01-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial
by: James H. McMahon, et al.
Published: (2020-10-01)

Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines
by: Browning DJ, et al.
Published: (2018-05-01)

Implications of the use of hydroxychloroquine on cardioactive drugs
by: Soumitra Ghosh, et al.
Published: (2021-01-01)

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
by: Ruth Fernandez-Ruiz, et al.
Published: (2020-08-01)

Macular toxicity after short-term hydroxychloroquine therapy
by: Isil Pasaoglu, et al.
Published: (2019-01-01)

Cutaneous purpura of Sjögren syndrome successfully treated with hydroxychloroquine
by: Grace A. Hile, BS, et al.
Published: (2017-07-01)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
by: Atiya R Faruqui, et al.
Published: (2021-01-01)

“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial”
by: Luciana Teofili, et al.
Published: (2020-10-01)

The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
by: Hamid Reza Samimagham, et al.
Published: (2020-10-01)

Hydroxychloroquine-associated pigmentation after extravasation injury
by: Keunyoung Hur, MD, et al.
Published: (2021-06-01)

The effect of propolis supplementation on clinical symptoms in patients with coronavirus (COVID-19): A structured summary of a study protocol for a randomised controlled trial
by: Mahsa Miryan, et al.
Published: (2020-12-01)